ArticleNAR cancer2025

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.

Daniel Andrés Colón-Ríos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.